Skip to main content
SpringerLink
Log in

Erythema Nodosum

  • Chapter
  • First Online:
European Handbook of Dermatological Treatments

  • 41 Accesses

Abstract

Erythema nodosum (EN) is typically characterized by suddenly symmetrically appearing deep painful red nodules on the pretibial area. It rarely recurs, but in some cases it becomes chronic. Histopathologically, EN is a septal panniculitis without vasculitis. EN is probably a hypersensitivity reaction to a known or unknown antigen. A physician diagnosing EN always has to consider it as a secondary disease. The most common underlying causes are infections (especially streptococcal), inflammatory bowel diseases, sarcoidosis, and drugs, and it can also be idiopathic. After ruling out erysipelas/cellulitis, thrombophlebitis, insect bite, or urticaria, other panniculitides and vasculitides have to be considered in differential diagnoses. It is self-limited; therefore, the therapy is often only symptomatic besides eliminating or treating aggravating causes. Physical pain relief methods (bed rest and cooling the inflamed skin) are the bases of symptomatic care. EN quickly responds to systemic steroid, but in most cases its use is neither recommended nor necessary. Systemic therapeutic options consist mainly of nonsteroidal anti-inflammatory drugs; in unresponsive cases, potassium iodine, colchicine, dapsone, hydroxychloroquine, thalidomide, TNF alpha inhibitors, and rarely other immunosuppressant and chemotherapeutic agents are the therapeutic options. EN usually resolves without any remaining sign. From the treatment choices, physicians should choose the best according to the possible or proven underlying/aggravating agent and also consider that most of the drugs recommended based on case reports and personal experiences are off-label.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 349.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 449.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Acosta KA, Haver MC, Kelly B. Etiology and therapeutic management of erythema nodosum during pregnancy: an update. Am J Clin Dermatol. 2013;14(3):215–22.

    Article  PubMed  Google Scholar 

  • Alloway JA, Franks LK. Hydroxychloroquine in the treatment of chronic erythema nodosum. Br J Dermatol. 1995;132(4):661–2.

    Article  CAS  PubMed  Google Scholar 

  • Aydin-Teke T, Tanir G, Bayhan GI, Metin O, Oz N. Erythema nodosum in children: evaluation of 39 patients. Turk J Pediatr. 2014;56(2):144–9.

    PubMed  Google Scholar 

  • Blake T, Manahan M, Rodins K. Erythema nodosum—a review of an uncommon panniculitis. Dermatol Online J. 2014;20(4):22376.

    Article  PubMed  Google Scholar 

  • Brodell RT, Mehrabi D. Underlying causes of erythema nodosum. Lesions may provide clue to systemic disease. Postgrad Med. 2000;108(6):147–9.

    Article  CAS  PubMed  Google Scholar 

  • Chowaniec M, Starba A, Wiland P. Erythema nodosum—review of the literature. Reumatologia. 2016;54(2):79–82.

    Article  PubMed  PubMed Central  Google Scholar 

  • Chowdhry S, Shukla A, D’Souza P, Dhali T, Jaiswal P. Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor etanercept. Int J Mycobacteriol. 2016;5(2):223–5.

    Article  PubMed  Google Scholar 

  • Costa RO, Macedo PM, Carvalhal A, Bernardes-Engemann AR. Use of potassium iodide in dermatology: updates on an old drug. An Bras Dermatol. 2013;88(3):396–402.

    Article  PubMed  PubMed Central  Google Scholar 

  • Daniela M, Pérez-Garza S, Chavez-Alvarez, Ocampo-Candiani M, Gomez-Flores. Erythema Nodosum: A Practical Approach and Diagnostic Algorithm American Journal of Clinical Dermatology. 2021;22(3)367–78. https://doi.org/10.1007/s40257-021-00592-w.

  • Darlong J, Govindharaj P, Charles DE, Menzies A, Mani S. Experiences with thalidomide for erythema nodosum leprosum- a retrospective study. Lepr Rev. 2016;87(2):211–20.

    Article  PubMed  Google Scholar 

  • Davatchi F, Sadeghi Abdollahi B, Tehrani Banihashemi A, Shahram F, Nadji A, Shams H, et al. Colchicine versus placebo in Behcet’s disease: randomized, double-blind, controlled crossover trial. Mod Rheumatol. 2009;19(5):542–9.

    Article  CAS  PubMed  Google Scholar 

  • De Simone C, Caldarola G, Scaldaferri F, Petito V, Perino F, Arena V, et al. Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum. Int J Dermatol. 2016;55(5):e289–94.

    Article  PubMed  Google Scholar 

  • Dogan S, Karaduman A, Evans SE. Clinical and laboratory characteristics of patients with erythema nodosum. Skinmed. 2016;14(2):99–103.

    PubMed  Google Scholar 

  • Fox MD, Schwartz RA. Erythema nodosum. Am Fam Physician. 1992;46(3):818–22.

    CAS  PubMed  Google Scholar 

  • Friedman ES, LaNatra N, Stiller MJ. NSAIDs in dermatologic therapy: review and preview. J Cutan Med Surg. 2002;6(5):449–59.

    Article  PubMed  Google Scholar 

  • Ghaoui N, Hanna E, Abbas O, Kibbi AG, Kurban M. Update on the use of dapsone in dermatology. Int J Dermatol. 2020;59(7):787–95.

    Article  CAS  PubMed  Google Scholar 

  • Golisch KB, Gottesman SP, Segal RJ. Compression stockings as an effective treatment for erythema nodosum: case series. Int J Womens Dermatol. 2017;3(4):231–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hafsi W, Badri T. Erythema nodosum. Treasure Island, FL: StatPearls; 2020. https://www.ncbi.nlm.nih.gov/books/NBK470369/#article-21301.s1.

    Google Scholar 

  • Hassan I, Keen A. Potassium iodide in dermatology. Indian J Dermatol Venereol Leprol. 2012;78(3):390–3.

    Article  PubMed  Google Scholar 

  • Jitendra SSV, Bachaspatimayum R, Devi AS, Rita S. Azathioprine in chronic recalcitrant erythema nodosum leprosum: a case report. J Clin Diagn Res. 2017;11(8):FD01–FD2.

    PubMed  PubMed Central  Google Scholar 

  • Kar BR, Babu R. Methotrexate in resistant ENL. Int J Lepr Other Mycobact Dis. 2004;72(4):480–2.

    Article  PubMed  Google Scholar 

  • Katerina D, Viktor S. Covid‐19 vaccine associated erythema nodosum: Factors to consider Dermatologic Therapy. 2022;35(5). https://doi.org/10.1111/dth.v35.5 https://doi.org/10.1111/dth.15410.

  • Kilic Y, Kamal S, Jaffar F et al. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease (2023): A Systematic Review and Meta-analysis Abstract Inflammatory Bowel Diseases https://doi.org/10.1093/ibd/izad061.

  • Kim BS, Kim JY, Lee JG, Cho Y, Huh KH, Kim MS, et al. Immune modulatory effect of thalidomide on T cells. Transplant Proc. 2015;47(3):787–90.

    Article  CAS  PubMed  Google Scholar 

  • Leung AKC, Leong KF, Lam JM. Erythema nodosum. World J Pediatr. 2018;14(6):548–54.

    Article  PubMed  Google Scholar 

  • Mossner R, Zimmer L, Berking C, Hoeller C, Loquai C, Richtig E, et al. Erythema nodosum-like lesions during BRAF inhibitor therapy: report on 16 new cases and review of the literature. J Eur Acad Dermatol Venereol. 2015;29(9):1797–806.

    Article  CAS  PubMed  Google Scholar 

  • Narang T, Kaushik A, Dogra S. Apremilast in chronic recalcitrant erythema nodosum leprosum: a report of two cases. Br J Dermatol. 2020;182(4):1034–7.

    Article  CAS  PubMed  Google Scholar 

  • Negera E, Walker SL, Bobosha K, Howe R, Aseffa A, Dockrell HM, et al. T-cell regulation in erythema nodosum leprosum. PLoS Negl Trop Dis. 2017;11(10):e0006001.

    Article  PubMed  PubMed Central  Google Scholar 

  • Negera E, Walker SL, Lema T, Aseffa A, Lockwood DN, Dockrell HM. Complement C1q expression in erythema nodosum leprosum. PLoS Negl Trop Dis. 2018;12(3):e0006321.

    Article  PubMed  PubMed Central  Google Scholar 

  • Paravar T, Lee DJ. Thalidomide: mechanisms of action. Int Rev Immunol. 2008;27(3):111–35.

    Article  CAS  PubMed  Google Scholar 

  • Passarini B, Infusino SD. Erythema nodosum. G Ital Dermatol Venereol. 2013;148(4):413–7.

    CAS  PubMed  Google Scholar 

  • Phillips FM, Verstockt B, Sebastian S, Ribaldone DG, Vavricka S, Katsanos K, et al. Inflammatory cutaneous lesions in inflammatory bowel disease treated with vedolizumab or ustekinumab: an ECCO CONFER multicentre case series. J Crohns Colitis. 2020;14:1488.

    Article  PubMed  Google Scholar 

  • Polycarpou A, Walker SL, Lockwood DN. A systematic review of immunological studies of erythema nodosum leprosum. Front Immunol. 2017;8:233.

    Article  PubMed  PubMed Central  Google Scholar 

  • Porges T, Shafat T, Sagy I, Zeller L, Bartal C, Khutarniuk T, et al. Clinical, epidemiological, and etiological changes in erythema nodosum. Isr Med Assoc J. 2018;20(12):770–2.

    PubMed  Google Scholar 

  • Porto LAB, Grossi MAF, de Alecrim ES, Xavier M, Paiva ESF, Pires AS, et al. Deep venous thrombosis in patients with erythema nodosum leprosum in the use of thalidomide and systemic corticosteroid in reference service in belo horizonte, minas gerais. Case Rep Dermatol Med. 2019;2019:8181507.

    PubMed  PubMed Central  Google Scholar 

  • Requena L, Yus ES. Panniculitis. Part I. mostly septal panniculitis. J Am Acad Dermatol. 2001;45(2):163–83; quiz 84–6.

    Article  CAS  PubMed  Google Scholar 

  • Santos JRS, Vendramini DL, Nery J, Avelleira JCR. Etanercept in erythema nodosum leprosum. An Bras Dermatol. 2017;92(4):575–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Sardana K, Sinha S, Sachdeva S. Hydroxychloroquine in dermatology and beyond: recent update. Indian Dermatol Online J. 2020;11(3):453–64.

    Article  PubMed  PubMed Central  Google Scholar 

  • Schwartz RA, Nervi SJ. Erythema nodosum: a sign of systemic disease. Am Fam Physician. 2007;75(5):695–700.

    PubMed  Google Scholar 

  • Siemanowski B, Regueiro M. Efficacy of infliximab for extraintestinal manifestations of inflammatory bowel disease. Curr Treat Options Gastroenterol. 2007;10(3):178–84.

    Article  PubMed  Google Scholar 

  • Silva PHL, Santos LN, Mendes MA, Nery JAC, Sarno EN, Esquenazi D. Involvement of TNF-producing CD8(+) effector memory T cells with immunopathogenesis of erythema nodosum leprosum in leprosy patients. Am J Trop Med Hyg. 2019;100(2):377–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Singh SM, Narang T, Dogra S, Handa S. Self-perceived emotional side effects of systemic corticosteroid therapy in dermatology patients. Indian J Dermatol Venereol Leprol. 2015;81(6):655.

    Article  PubMed  Google Scholar 

  • Song JS, Halim K, Vleugels RA, Merola JF. Dapsone for treatment of erythema nodosum. Dermatol Online J. 2016;22(2):13030/qt8z782742.

    Article  PubMed  Google Scholar 

  • Sterling JB, Heymann WR. Potassium iodide in dermatology: a 19th century drug for the 21st century-uses, pharmacology, adverse effects, and contraindications. J Am Acad Dermatol. 2000;43(4):691–7.

    Article  CAS  PubMed  Google Scholar 

  • Suter P, Mooser B, Pham Huu Thien HP. Erythema nodosum as a cutaneous manifestation of COVID-19 infection. BMJ Case Rep. 2020;13(7):e236613.

    Article  PubMed  Google Scholar 

  • Tanaka K, Suemasu S, Ishihara T, Tasaka Y, Arai Y, Mizushima T. Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis. Eur J Pharmacol. 2009;603(1–3):120–32.

    Article  CAS  PubMed  Google Scholar 

  • Varas P, Antunez-Lay A, Bernucci JM, Cossio L, Gonzalez S, Eymin G. Erythema nodosum: analysis of 91 hospitalized patients. Rev Med Chil. 2016;144(2):162–8.

    Article  PubMed  Google Scholar 

  • Walker SL, Waters MF, Lockwood DN. The role of thalidomide in the management of erythema nodosum leprosum. Lepr Rev. 2007;78(3):197–215.

    Article  PubMed  Google Scholar 

  • Walker SL, Balagon M, Darlong J, Doni SN, Hagge DA, Halwai V, et al. ENLIST 1: an international multi-centre cross-sectional study of the clinical features of erythema nodosum leprosum. PLoS Negl Trop Dis. 2015;9(9):e0004065.

    Article  PubMed  PubMed Central  Google Scholar 

  • Wallace SL. Erythema nodosum treatment with colchicine. JAMA. 1967;202(11):1056.

    Article  CAS  PubMed  Google Scholar 

  • Wendon D. In: Livingstone C, editor. Weedon’s skin pathology 3rd Edition; 2010. p. 477. http://www.sciencedirect.com/science/article/pii/B9780702034855000188.

    Google Scholar 

  • Wozel G, Blasum C. Dapsone in dermatology and beyond. Arch Dermatol Res. 2014;306(2):103–24.

    Article  CAS  PubMed  Google Scholar 

  • Wu JJ, Huang DB, Pang KR, Hsu S, Tyring SK. Thalidomide: dermatological indications, mechanisms of action and side-effects. Br J Dermatol. 2005;153(2):254–73.

    Article  CAS  PubMed  Google Scholar 

  • Zippi M, Pica R, De Nitto D, Paoluzi P. Biological therapy for dermatological manifestations of inflammatory bowel disease. World J Clin Cases. 2013;1(2):74–8.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary

    Eva Remenyik

Authors
  1. Eva Remenyik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eva Remenyik .

Editor information

Editors and Affiliations

  1. Andreas Syggros Hospital, Athens State University, Athens, Greece

    Andreas D. Katsambas

  2. Research Center CSRMR, Marconi University, Rome, Roma, Italy

    Torello M. Lotti

  3. Andreas Syggros Hospital, Athens State University, Athens, Greece

    Clio Dessinioti

  4. Dermatoloy Unit, Livorno Hospital, Livorno, Italy

    Angelo Massimiliano D'Erme

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Remenyik, E. (2023). Erythema Nodosum. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D'Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Cham. https://doi.org/10.1007/978-3-031-15130-9_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-15130-9_27

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-15129-3

  • Online ISBN: 978-3-031-15130-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation